Susquehanna International Group, LLP Biotechnology

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
HRMY
Harmony Biosciences Holdings, Inc.
CALL
$4.09 Million
102K
Q2 2024
New holding
CAPR
Capricor Therapeutics, Inc.
CALL
$3.98 Million
262K
Q3 2024
Added 204.74%
RXRX
Recursion Pharmaceuticals, Inc.
CALL
$3.9 Million
592K
Q3 2024
Reduced 21.73%
SNDX
Syndax Pharmaceuticals Inc
PUT
$3.86 Million
200K
Q3 2024
Added 65.35%
GERN
Geron Corp
CALL
$3.85 Million
849K
Q3 2024
Added 23.2%
APLT
Applied Therapeutics Inc.
CALL
$3.81 Million
449K
Q3 2024
Reduced 70.02%
CLDX
Celldex Therapeutics, Inc.
CALL
$3.67 Million
108K
Q3 2024
Added 35.05%
JANX
Janux Therapeutics, Inc.
CALL
$3.63 Million
80K
Q3 2024
Added 117.13%
VERA
Vera Therapeutics, Inc.
PUT
$3.62 Million
82K
Q3 2024
Added 77.19%
CLDX
Celldex Therapeutics, Inc.
PUT
$3.6 Million
106K
Q3 2024
Added 35.05%
SWTX
Spring Works Therapeutics, Inc.
PUT
$3.5 Million
109K
Q3 2024
Reduced 19.55%
VRNA
Verona Pharma PLC
PUT
$3.49 Million
121K
Q2 2024
New holding
AUPH
Aurinia Pharmaceuticals Inc.
CALL
$3.41 Million
465K
Q3 2024
Reduced 82.35%
IONS
Ionis Pharmaceuticals Inc
CALL
$3.3 Million
82.3K
Q3 2024
Reduced 40.29%
ETNB
89bio, Inc.
PUT
$3.09 Million
418K
Q3 2024
Added 9.91%
IMTX
Immatics N.V.
PUT
$2.96 Million
259K
Q3 2024
New holding
ARDX
Ardelyx, Inc.
PUT
$2.95 Million
429K
Q3 2024
Added 43.29%
EWTX
Edgewise Therapeutics, Inc.
PUT
$2.9 Million
109K
Q3 2024
Added 1095.16%
BEAM
Beam Therapeutics Inc.
PUT
$2.76 Million
113K
Q3 2024
Reduced 48.33%
AGIO
Agios Pharmaceuticals, Inc.
CALL
$2.6 Million
58.6K
Q3 2024
Added 61.11%
ALT
Altimmune, Inc.
PUT
$2.55 Million
416K
Q3 2024
Reduced 58.06%
AKRO
Akero Therapeutics, Inc.
PUT
$2.52 Million
87.9K
Q3 2024
Reduced 39.33%
IONS
Ionis Pharmaceuticals Inc
PUT
$2.35 Million
58.7K
Q3 2024
Reduced 40.29%
QURE
Uni Qure N.V.
PUT
$2.34 Million
474K
Q3 2024
Reduced 36.46%
FOLD
Amicus Therapeutics, Inc.
PUT
$2.29 Million
214K
Q3 2024
Reduced 26.81%
VRDN
Viridian Therapeutics, Inc.\De
PUT
$2.26 Million
99.5K
Q3 2024
Added 54.25%
MRUS
Merus N.V.
CALL
$2.23 Million
44.7K
Q3 2024
New holding
IMCR
Immunocore Holdings PLC
CALL
$2.17 Million
69.8K
Q3 2024
New holding
ALT
Altimmune, Inc.
CALL
$2.11 Million
344K
Q3 2024
Reduced 58.06%
TERN
Terns Pharmaceuticals, Inc.
CALL
$2.08 Million
249K
Q3 2024
Added 28.04%
ARDX
Ardelyx, Inc.
CALL
$2.02 Million
293K
Q3 2024
Added 43.29%
ZLAB
Zai Lab LTD
PUT
$2.01 Million
83.2K
Q2 2024
Reduced 11.21%
PTCT
Ptc Therapeutics, Inc.
CALL
$2 Million
54K
Q3 2024
Added 36.81%
IBRX
Immunity Bio, Inc.
CALL
$1.99 Million
537K
Q3 2024
Added 10.28%
FULC
Fulcrum Therapeutics, Inc.
CALL
$1.99 Million
557K
Q3 2024
Reduced 55.18%
TVTX
Travere Therapeutics, Inc.
PUT
$1.98 Million
141K
Q3 2024
Reduced 63.44%
RYTM
Rhythm Pharmaceuticals, Inc.
PUT
$1.97 Million
37.6K
Q3 2024
Reduced 10.96%
ARCT
Arcturus Therapeutics Holdings Inc.
CALL
$1.95 Million
84.1K
Q3 2024
Reduced 20.25%
PRTA
Prothena Corp Public LTD CO
CALL
$1.89 Million
113K
Q3 2024
Added 40.38%
CAPR
Capricor Therapeutics, Inc.
PUT
$1.85 Million
122K
Q3 2024
Added 204.74%
NTLA
Intellia Therapeutics, Inc.
CALL
$1.84 Million
89.5K
Q3 2024
Added 89.02%
SLS
Sellas Life Sciences Group, Inc.
CALL
$1.82 Million
1.46M
Q3 2023
Added 355.61%
SRRK
Scholar Rock Holding Corp
PUT
$1.81 Million
226K
Q3 2024
Reduced 1.15%
CRMD
Cor Medix Inc.
PUT
$1.79 Million
222K
Q3 2024
Reduced 39.44%
QURE
Uni Qure N.V.
CALL
$1.77 Million
358K
Q3 2024
Reduced 36.46%
MNKD
Mannkind Corp
PUT
$1.76 Million
280K
Q3 2024
Reduced 59.2%
BMEA
Biomea Fusion, Inc.
PUT
$1.75 Million
173K
Q3 2024
Reduced 66.94%
RNA
Avidity Biosciences, Inc.
CALL
$1.74 Million
37.9K
Q3 2024
Reduced 1.56%
ARCT
Arcturus Therapeutics Holdings Inc.
PUT
$1.71 Million
73.8K
Q3 2024
Reduced 20.25%
Filter Shares Options
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email